|Bid||110.10 x 100|
|Ask||110.13 x 100|
|Day's Range||109.22 - 110.20|
|52 Week Range||83.34 - 114.00|
|PE Ratio (TTM)||18.07|
|Forward Dividend & Yield||1.84 (1.73%)|
|1y Target Est||N/A|
On the 10 May 2018, Celanese Corporation (NYSE:CE) will be paying shareholders an upcoming dividend amount of $0.54 per share. However, investors must have bought the company’s stock before 27Read More...
LyondellBasell (LYB) is expected to report adjusted earnings per share of $2.74 in 1Q18, a whopping 37% increase on a year-over-year basis. In 1Q17, LYB reported adjusted earnings per share of $2.00. In 2017, LYB managed to beat analyst estimates twice, but also missed estimates twice. It remains to be seen whether LYB can change the trend in fiscal 2018.
rheumatoid arthritis drug baricitinib, Eli Lilly chairman and CEO David Ricks on an earnings call Tuesday expressed confidence in the benefit-risk profile of both doses of the treatment. The advisory panel recommended that the FDA approve the 2-mg dose of baricitinib, but not the 4-mg dose for the proposed indication based on the adequacy of the safety and benefit-risk profiles. "While we are pleased that the FDA's arthritis advisory committee supported the efficacy of both 2 mg and 4 mg of baricitinib in RA and 2 mg overall, we are disappointed that the committee did not recommend approval of the 4-mg dose," Ricks said.
Celanese Corporation (CE) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
Zacks.com featured highlights include: Ruth's, LHC, Celanese, Northern and Interactive Brokers
Earnings estimates embody analysts' opinions of factors such as sales growth, product demand, competitive industry environment, profit margins and cost controls.
Cabot (CBT) inks deal with Midwest Energy Emissions, under which, it will leverage the latter's patented technologies to enhance its current portfolio of mercury removal solutions.
Celanese shares were booming as the company unveiled strong quarterly results. From a revenue standpoint, Celanese also impressed, bringing in $1.85 billion for its first quarter, marking a 26% increase compared to the year-ago period. “The on-going success in our businesses gives us confidence that we can grow adjusted earnings per share by 20-25 percent in 2018,” said Mark Rohr, Celanese chairman and CEO.
The Irving, Texas-based company said it had profit of $2.66 per share. Earnings, adjusted for non-recurring costs and to account for discontinued operations, were $2.79 per share. The results exceeded ...
Gainers: NF Energy Saving Corp (NASDAQ: NFEC ) shares are up 8 percent after a 13-D filing from Bi Yongquan showed a 19.8-percent stake. Dynavax Technologies Corporation (NASDAQ: DVAX ) shares are up ...
Bank of America (BAC) reported strong beats on both its top and bottom lines this morning. The price action is best understood in conjunction with the events that unfolded last week. In a perverse turn of events last week, large-cap banks reported Q1 results on Friday morning and largely beat consensus expectations for EPS and revenue growth, but fell victim to a dramatic selloff after markets opened.
On April 10, 2018, Celanese (CE) announced price hikes for several products. These price hikes are effective immediately or according to the respective contracts. This price increase is expected to impact the Asia Outside China region. Below are the details of the price increases: Butyl acetate prices are expected to increase $50.00 per metric ton in Asia Outside China. Ethyl acetate prices are expected to increase $50.00 per metric ton in Asia Outside China. Vinyl acetate monomer (or VAM) prices are expected to see a price hike of $100.00 per metric ton in Asia Outside China. ...
Zacks.com highlights: Microchip Technology, AMC Networks, LyondellBasell Industries N.V., Applied Materials and Celanese
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment that are likely to lend support to margins.
Analysts recommended a target price of $119.00 for Celanese, which implies a return potential of 20.30% over the closing price of $98.85 as of April 4, 2018. Celanese reported better-than-expected 4Q17 earnings. Celanese’s growth is expected to be supported by its ability to hike product prices.